ArticleFrontiers in public health2025
Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany-a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infections.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Population health and implementation outcomes of self-testing for SARS-CoV-2 using antigen detecting diagnostics: a systematic review and meta-analysis.EClinicalMedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute respiratory infections (ARI) are the most common human infections. Diagnostic testing for respiratory pathogens is largely restricted to medical institutions. Self-testing may allow for real-time epidemiological monitoring of ARI pathogens, in particular in individuals not seeking medical attention. Methods: Adults from the VACCELERATE Volunteer Registry received a test-kit for multiple respiratory antigens, a laminar flow device (LFD) detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza viruses A and B, respiratory syncytial virus (RSV) and adenovirus (ADV) from a single nasal swab. During one winter season, participants self-tested upon ARI symptoms, reported LFD result as well as symptoms, vaccination history, and any underlying conditions. Participants who remained without ARI symptoms self-tested on the last day of the study period. Results: Between December 7, 2022, and June 2, 2023, 1,429 participants communicated their self-testing results. Of these 1,119 (78.3%) individuals had developed ARI symptoms and self-tested until May 31, 2023. Overall, 359 of 1,119 (32.1%) tests were positive with 17 (1.5%) co-detections, resulting in 377 detected pathogens overall. Thirteen tests (1.2%) were invalid or failed technically, and 747 (66.8%) were negative. The most frequently detected pathogen was SARS-CoV-2 ( Conclusion: This study allowed real-time reporting of five endemic ARI pathogens in a citizen science project. Symptom burden was highest in influenza A. Seasonal and off-seasonal RSV detection hint toward relevant RSV circulation in adults all year round.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.